Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Silva Effie DSVP, General Counsel & Secy | Option exercise | M | — 2,109 sh | Mar 5, 2026 |
| 17 | Vicente MonicaSVP, Chief Financial Officer | Option exercise | M | — 179 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 17 | Puri Michal NathChief Human Resources Officer | Grant or award | A | — 40.1K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 17 | Peters Todd KennethVice President, Engineering | Grant or award | A | — 1,650 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 17 | Scanlon Thomas ACorporate Controller & PAO | Grant or award | A | — 1,650 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 17 | Williams Paul AnthonySVP, Products Business | Grant or award | A | — 44.8K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 17 | Shen Zheng JohnDirector | Option exercise | M | — 1,217 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 17 | Ben Arye BarakGeneral Counsel | Grant or award | A | — 50.1K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 17 | Ruddy Marcella K.Chief Medical Officer | Grant or award | A | — 26.5K sh | Mar 5, 2026 traded Mar 4, 2026 |
| 16 | Glessner ColeenEVP, Quality & Ethics, and CPL | Tax withholding | F | $69K 8,199 sh | Mar 5, 2026 traded Mar 5, 2026 |
| 16 | Ma YingliCHIEF TECHNOLOGY OFFICER | Tax withholding | F | $237K 11.3K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 16 | Perl JessicaSVP, General Counsel, Corp Sec | Tax withholding | F | $55K 6,465 sh | Mar 5, 2026 traded Mar 5, 2026 |
| 16 | Anderson Woodrow DChief Accounting Officer | Tax withholding | F | $86K 2,682 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 16 | Sanfrey Jeffrey ScottChief Operating Officer | Option exercise | M | $64K 5,192 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 16 | Williams Paul AnthonySVP, Products Business | Tax withholding | F | $79K 9,397 sh | Mar 5, 2026 traded Mar 5, 2026 |
| 16 | O'Neill ShivGC AND CORP SEC | Tax withholding | F | $118K 4,738 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 16 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.17M 27.1K sh | Mar 5, 2026 traded Mar 5, 2026 |
| 16 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.37M 33.9K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 16 | Lowry Simon CSVP, R&D, CMO | Tax withholding | F | $90K 10.6K sh | Mar 5, 2026 traded Mar 5, 2026 |
| 16 | Coll Crespo BlasCHIEF MEDICAL OFFICER | Tax withholding | F | $248K 11.8K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 16 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.30M 29.3K sh | Mar 5, 2026 traded Mar 4, 2026 |
| 16 | Moylan MishaSee Remarks | Tax withholding | F | $62K 204 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 16 | Hartzel WilliamSVP, Bioservices | Tax withholding | F | $80K 9,493 sh | Mar 5, 2026 traded Mar 5, 2026 |
| 15 | Landry BenjaminGeneral Counsel | Tax withholding | F | $35K 20.8K sh | Mar 5, 2026 traded Mar 2, 2026 |
| 15 | Kalia KumudChief Information Officer | Option exercise | M | $286K 10.0K sh | Mar 5, 2026 traded Mar 4, 2026 |
| 15 | Kalia KumudChief Information Officer | Option exercise | M | $284K 10.0K sh | Mar 5, 2026 traded Mar 4, 2026 |
| 15 | Ostergaard TorbenCEO Spinnaker | Grant or award | A | — 9,874 sh | Mar 5, 2026 traded Mar 2, 2026 |
| 15 | Albert BenjaminDirector, CEO | Tax withholding | F | $8,243 4,966 sh | Mar 5, 2026 traded Mar 2, 2026 |
| 15 | Aiyar PriyaChief Legal Officer | Tax withholding | F | $411K 14.6K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 15 | Yoon JunCHIEF FINANCIAL OFFICER | Tax withholding | F | $468K 22.3K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 15 | Stienstra MichaelGM & Chief Insurance, HHIP | Grant or award | A | — 9,874 sh | Mar 5, 2026 traded Mar 2, 2026 |
| 14 | Feeley KevinCHIEF FINANCIAL OFFICER | Grant or award | A | — 15.3K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 14 | Steenberge Michael AnthonyChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $41K 2,342 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 13 | Randle Race A.CEO | Tax withholding | F | — 18.0K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 13 | Silva Effie DSVP, General Counsel & Secy | Option exercise | M | — 152 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 13 | Vicente MonicaSVP, Chief Financial Officer | Option exercise | M | — 2,480 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 13 | Boone Travis JDirector, PRESIDENT & CEO | Grant or award | A | — 73.3K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 13 | Ribeiro RamiroChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $44K 2,438 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 13 | Vicente MonicaSVP, Chief Financial Officer | Option exercise | M | — 2,480 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 13 | Gonzalez Lissette REVP, Chief Commercial Officer | Option exercise | M | — 4,861 sh | Mar 5, 2026 traded Mar 3, 2026 |